ConductScience.org, home

Paper762415

Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products.

Dvorak HF and 9 others. J Immunol, 1979. Cited by 225 papers, by iCite.

Cite this record

ConductScience Library. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. Papers, record 762415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/762415

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products.
PubMed
Journal
J Immunol
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
225
iCite
Relative citation ratio, by iCite
5.7
iCite
Revised in PubMed
2021-01-09
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dvorak HFH F
2Orenstein NSN S
3Carvalho ACA C
4Churchill WHW H
5Dvorak AMA M
6Galli SJS J
7Feder JJ
8Bitzer AMA M
9Rypysc JJ
10Giovinco PP

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bile Duct NeoplasmsMajor topic
Cell Transformation, NeoplasticMajor topic
FibrinMajor topic
Animals
Buffers
Capillary Permeability
Cell Line
Cells, Cultured
Cold Temperature
Female
Guinea Pigs
Kinetics
Male
Puromycin
Time Factors

Source PubMed

Download CSV of topics

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 225 citations.

PMIDTitleJournalYearIn PapersSource
42260750Inflammation induced by snake venoms optimizes envenomation.J Physiol2026https://conductscience.org/library/papers/42260750PubMed
39038038Simulation of Soluble and Bound VEGF-stimulated in vitro Capillary-like Network Formation on Deformed Substrate.PLoS Comput Biol2024https://conductscience.org/library/papers/39038038PubMed
38033338Systemic mapping of organ plasma extravasation at multiple stages of chronic heart failure.Front Physiol2023https://conductscience.org/library/papers/38033338PubMed
37079065Massively recruited sTLR9+ neutrophils in rapidly formed nodules at the site of tumor cell inoculation and their contribution to a pro-tumor microenvironment.Cancer Immunol Immunother2023https://conductscience.org/library/papers/37079065PubMed
36555234The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy.Int J Mol Sci2022https://conductscience.org/library/papers/36555234PubMed
36187473Endothelial cells and their role in the vasculature: Past, present and future.Front Cell Dev Biol2022https://conductscience.org/library/papers/36187473PubMed
34958805Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells.Microvasc Res2022https://conductscience.org/library/papers/34958805PubMed
34146582A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.Microvasc Res2021https://conductscience.org/library/papers/34146582PubMed
33834026Reconciling VEGF With VPF: The Importance of Increased Vascular Permeability for Stroma Formation in Tumors, Healing Wounds, and Chronic Inflammation.Front Cell Dev Biol2021https://conductscience.org/library/papers/33834026PubMed
32309582Discoveries Interview: Professor Harold F. Dvorak on the discovery of Vascular Endothelial Growth Factor (VEGF).Discoveries (Craiova)2016https://conductscience.org/library/papers/32309582PubMed
30101034Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15.Signal Transduct Target Ther2018https://conductscience.org/library/papers/30101034PubMed
28838996The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.Mol Cancer Ther2017https://conductscience.org/library/papers/28838996PubMed
26798356Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression.Stem Cells Int2016https://conductscience.org/library/papers/26798356PubMed
26757406Fit for the Eye: Aptamers in Ocular Disorders.Nucleic Acid Ther2016https://conductscience.org/library/papers/26757406PubMed
26697178Sp1-mediated nonmuscle myosin light chain kinase expression and enhanced activity in vascular endothelial growth factor-induced vascular permeability.Pulm Circ2015https://conductscience.org/library/papers/26697178PubMed
25568067Tumors: wounds that do not heal-redux.Cancer Immunol Res2015https://conductscience.org/library/papers/25568067PubMed
24690161The discovery of angiogenic growth factors: the contribution of Italian scientists.Vasc Cell2014https://conductscience.org/library/papers/24690161PubMed
23807899
Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer.
Open Nanomed J2011https://conductscience.org/library/papers/23807899PubMed
23456574From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.Stem Cell Rev Rep2013https://conductscience.org/library/papers/23456574PubMed
22674805Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability.Blood2012https://conductscience.org/library/papers/22674805PubMed

See all 57 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/762415

GET https://conductscience.org/api/papers/v1/762415/cited_by?page=2